Vir Biotechnology, Inc. VIR Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s other intangible assets—net?
- Vir Biotechnology, Inc. (VIR) reported other intangible assets—net of $7.78M in Q1 2026.
- How has Vir Biotechnology, Inc.'s other intangible assets—net changed year-over-year?
- Vir Biotechnology, Inc.'s other intangible assets—net decreased by 3.7% year-over-year, from $8.07M to $7.78M.
- What is the long-term trend for Vir Biotechnology, Inc.'s other intangible assets—net?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s other intangible assets—net has grown at a -25.3% compound annual growth rate (CAGR), from $33.82M to $7.85M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.